Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-59,000
Closed -$3.98M 13235
2025
Q3
$3.98M Buy
59,000
+7,200
+14% +$478K ﹤0.01% 4772
2025
Q2
$3.38M Buy
51,800
+15,100
+41% +$905K ﹤0.01% 4776
2025
Q1
$2.27M Buy
36,700
+18,600
+103% +$1.23M ﹤0.01% 5301
2024
Q4
$1.3M Sell
18,100
-61,100
-77% -$4.77M ﹤0.01% 6498
2024
Q3
$6.45M Buy
79,200
+25,200
+47% +$2.02M ﹤0.01% 3540
2024
Q2
$4.01M Sell
54,000
-47,600
-47% -$3.57M ﹤0.01% 4097
2024
Q1
$7.92M Buy
101,600
+52,000
+105% +$3.87M ﹤0.01% 3261
2023
Q4
$3.54M Sell
49,600
-2,600
-5% -$181K ﹤0.01% 4355
2023
Q3
$3.62M Buy
52,200
+15,500
+42% +$1.17M ﹤0.01% 4164
2023
Q2
$2.97M Sell
36,700
-37,800
-51% -$3.09M ﹤0.01% 4492
2023
Q1
$6.01M Sell
74,500
-24,100
-24% -$1.94M ﹤0.01% 3507
2022
Q4
$7.38M Buy
98,600
+1,000
+1% +$71.2K ﹤0.01% 3250
2022
Q3
$6.3M Buy
97,600
+33,000
+51% +$2.29M ﹤0.01% 3499
2022
Q2
$4.48M Sell
64,600
-44,400
-41% -$3.3M ﹤0.01% 4012
2022
Q1
$8.37M Sell
109,000
-30,900
-22% -$2.22M ﹤0.01% 3250
2021
Q4
$10.7M Sell
139,900
-49,900
-26% -$3.67M ﹤0.01% 2964
2021
Q3
$14M Buy
189,800
+35,800
+23% +$2.68M ﹤0.01% 2526
2021
Q2
$10.3M Buy
154,000
+90,100
+141% +$6.02M ﹤0.01% 3023
2021
Q1
$4.75M Buy
63,900
+37,400
+141% +$2.84M ﹤0.01% 4367
2020
Q4
$1.93M Sell
26,500
-49,900
-65% -$3.52M ﹤0.01% 5423
2020
Q3
$5.08M Buy
76,400
+32,200
+73% +$2.04M ﹤0.01% 3134
2020
Q2
$2.52M Sell
44,200
-15,800
-26% -$775K ﹤0.01% 4155
2020
Q1
$2.11M Sell
60,000
-900
-1% -$42.9K ﹤0.01% 4063
2019
Q4
$3.18M Buy
60,900
+14,100
+30% +$702K ﹤0.01% 3702
2019
Q3
$2.36M Buy
46,800
+12,400
+36% +$610K ﹤0.01% 4222
2019
Q2
$1.65M Sell
34,400
-59,300
-63% -$2.74M ﹤0.01% 4846
2019
Q1
$4.54M Sell
93,700
-29,900
-24% -$1.35M ﹤0.01% 3140
2018
Q4
$5.08M Buy
123,600
+38,400
+45% +$1.58M ﹤0.01% 2762
2018
Q3
$3.49M Buy
85,200
+900
+1% +$36.4K ﹤0.01% 3497
2018
Q2
$3.35M Buy
84,300
+59,700
+243% +$2.3M ﹤0.01% 3313
2018
Q1
$919K Sell
24,600
-49,700
-67% -$2.01M ﹤0.01% 4950
2017
Q4
$3.18M Buy
74,300
+9,900
+15% +$395K ﹤0.01% 3030
2017
Q3
$2.36M Sell
64,400
-2,200
-3% -$88.8K ﹤0.01% 3218
2017
Q2
$3.02M Sell
66,600
-1,100
-2% -$48.6K ﹤0.01% 2650
2017
Q1
$2.88M Buy
67,700
+41,200
+155% +$1.68M ﹤0.01% 2633
2016
Q4
$1.06M Sell
26,500
-3,500
-12% -$135K ﹤0.01% 3775
2016
Q3
$1.17M Sell
30,000
-100
-0.3% -$3.77K ﹤0.01% 3630
2016
Q2
$1.04M Buy
30,100
+3,800
+14% +$132K ﹤0.01% 3503
2016
Q1
$907K Sell
26,300
-51,800
-66% -$1.81M ﹤0.01% 3607
2015
Q4
$3.02M Sell
78,100
-97,200
-55% -$3.78M ﹤0.01% 2321
2015
Q3
$6.86M Buy
175,300
+121,100
+223% +$4.8M 0.01% 1629
2015
Q2
$2.06M Sell
54,200
-6,400
-11% -$224K ﹤0.01% 3031
2015
Q1
$2M Buy
60,600
+35,800
+144% +$1.1M ﹤0.01% 3062
2014
Q4
$663K Sell
24,800
-10,600
-30% -$274K ﹤0.01% 4321
2014
Q3
$861K Sell
35,400
-3,000
-8% -$75.8K ﹤0.01% 3894
2014
Q2
$973K Buy
38,400
+18,800
+96% +$439K ﹤0.01% 3523
2014
Q1
$421K Sell
19,600
-108,600
-85% -$2.34M ﹤0.01% 4601
2013
Q4
$2.87M Buy
128,200
+104,000
+430% +$2.29M ﹤0.01% 2188
2013
Q3
$500K Sell
24,200
-5,300
-18% -$113K ﹤0.01% 3817
2013
Q2
$569K Buy
+29,500
New +$616K ﹤0.01% 3706

Other funds holding HOLX

Citadel Advisors's HOLX Position: Q1 2026 in Review

Citadel Advisors increased its Hologic (HOLX) stake by 71% in Q1 2026, buying an estimated $34M and bringing the position to 1,090,660 shares worth $82.4M. The position accounts for 0.01% of the portfolio, ranked #947.

Citadel Advisors first reported a position in HOLX in Q2 2013 and has held it in 47 quarters since. The position peaked at $434M in Q3 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Citadel Advisors held 1,090,660 shares of Hologic worth $82.4M as of Q1 2026.
  • Citadel Advisors bought 452,018 Hologic shares in Q1 2026, an estimated $34M.
  • Hologic made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #947 holding.
  • Citadel Advisors first reported a position in Hologic in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Hologic position peaked at $434M in Q3 2023.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.